In a study published by Stemick et al. (2022), the acceptance of CUREO® therapy was assessed. The results were very significant: * 95% of patients were more motivated by virtual reality therapy * Almost all patients (97%) would like to continue with VR therapy The study is titled "Increased therapy motivation through innovative virtual reality therapy" and was published in the journal "Nervenheilkunde" in 2022. Find out more about the current state of research on virtual reality on our website www.cureosity.com and arrange your personal consultation today via the link in our bio. #CUREO #EN
CUREosity GmbH
Herstellung medizinischer Geräte
Düsseldorf, North Rhine-Westphalia 2.555 Follower:innen
virtual therapy - real success
Info
CUREosity is an award-winning medtech company based in Düsseldorf, Germany, focusing on Virtual Reality therapy through gamification. With our vision to revolutionize traditional rehabilitation, we develop VR-based therapy applications for clinics and practices. The advantages of the one-of-a-kind therapy system CUREO are (among others): Evidence-based therapeutic success, sustainable relief of personnel, increased patient motivation, a wide range of applications and an easy and intuitive usability. In a collaborative approach with scientists, doctors and therapists from major clinics and partner practices, our developers and in-house medical experts are constantly striving to further improve therapy by making CUREO even more effective for patient as well as even more efficient for medical personnel. If you’re interested in learning more about CUREO for your clinic or practice, please visit our website or contact our sales personnel: https://www.cureosity.de/en/therapie-mit-cureo If you want to be part of our team and support us in delivering Virtual Reality with Real Successes, then contact us on LinkedIn, visit our website and apply at [email protected]
- Website
-
http://cureosity.com
Externer Link zu CUREosity GmbH
- Branche
- Herstellung medizinischer Geräte
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Düsseldorf, North Rhine-Westphalia
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2018
- Spezialgebiete
- VR, Virtual Reality, VR Therapy, VR Therapy Games, VR Applications, Rehabilitation, Software, SaaS, MedTech, Physical Therapy, Occupational Therapy und Gamification
Orte
-
Primär
Hansaallee 299
Düsseldorf, North Rhine-Westphalia 40549, DE
Beschäftigte von CUREosity GmbH
-
Allart de Voogd vd Straaten
Game Developer
-
Ahmet Levent Kandemir
Data Scientist @CUREosity | PhD candidate in Informatics
-
Oliver Locher
Key Account Manager | HealthCare | SaaS-Sales
-
Dr. Katarina Buchmann
Reimbursement & Medical Affairs @ CUREosity GmbH | MSc. Neuropsychology | MedTech | digital Health
Updates
-
Danke noch einmal für die erfolgreiche Zusammenarbeit an Dr. Sebastian Weller und das gesamte Team von ADVANT Beiten!
ADVANT Beiten hat in einem Team um den federführenden Partner Dr. Sebastian Weller die CUREosity GmbH bei einer Wachstumsfinanzierungsrunde beraten, die dem Med-Tech-Unternehmen insgesamt ca. EUR 3,8 Millionen von Bestands- und Neuinvestoren eingebracht hat. Die CUREosity GmbH ist ein Scale Up aus Düsseldorf, welches innovative Therapie-Software unter Nutzung von Virtual Reality (VR)-Brillen entwickelt. 🤝 Unser Beratungsteam: Dr. Sebastian Weller, Markus Schönherr, Sarah Heinrichs und Simon Litterst. Unsere #Pressemitteilung finden Sie hier: https://t1p.de/22r30 #advantbeiten #venturecapital
-
With CUREO®4 therapy comes to the patient and not the other way around: * At bedside in acute and early rehabilitation * In your clinic or practice * In the patient's private premises during aftercare The system is easy to transport in a robust, mobile, and easy-care case that you can take with you anywhere you go. Rehabilitation has never been so versatile or easy. Find even more information about virtual reality therapy on our website www.cureosity.com and arrange your personal consultation today via the link in our bio. #CUREO #EN
-
CUREosity GmbH hat dies direkt geteilt
🚀 3,8 Millionen Euro für CUREosity GmbH! 🚀 Wir berichten über die erfolgreiche Wachstumsfinanzierung der Düsseldorfer CUREosity GmbH. Das MedTech-Unternehmen hat 3,8 Millionen Euro von Investoren erhalten. Mit diesem Kapital soll die kommerzielle Expansion vorangetrieben und die VR-Therapiesoftware CUREO® weiterentwickelt werden. Erfahrt mehr über diesen wichtigen Meilenstein auf der Startbase. 🌟 👉 https://lnkd.in/dh--uAbD #StartupNews #MedTech #VR #GrowthFunding #CUREosity
-
-
CUREosity GmbH hat dies direkt geteilt
Germany-based CUREosity GmbH, a MedTech company, has secured €3.8M in a growth financing round from existing and new investors. 💼💉 CUREosity is known for its Virtual Reality therapy system called CUREO for clinics and practices. Read more about the deal here: https://lnkd.in/gCz5Feh6 TVF | TechVision Fonds, NOMAINVEST, ADVANT Beiten, Forvis Mazars, Stefan Arand, Marco Faulhammer, Caesar van Heyningen #MedTech #Healthcare #Funding
-
CUREosity GmbH hat dies direkt geteilt
Medtech company CUREosity GmbH secures additional €3.8M for VR therapy https://buff.ly/45B2yLi
-
-
CUREosity GmbH announces the successful conclusion of a growth financing round. A total of 3.8 million euros was committed by existing and new investors in the completed growth financing round. Caesar van Heyningen (CEO): "The current successful course – consisting of scaling markets and high-quality updates of our therapy software – is strengthened by this financing. We plan to invest heavily in commercial expansion, incorporating tomorrow's technological possibilities into our product roadmap today. With this financing round, we can ensure financial independence and sustainable business operations. A privilege – especially in tight market conditions." Among others, the existing investor TVF | TechVision Fonds and the Belgian family office NOMAINVEST have contributed as new co-investors. The growth financing round was accompanied by the law firms ADVANT Beiten and Forvis Mazars Group, whom CUREOSITY would like to thank for their productive and successful collaboration. More information in our blog: https://lnkd.in/djagjRWu #CUREosity #EN
-
-
In the independent study by Lülsdorff et al. (2023), the effectiveness of Virtual Reality in the treatment of stroke patients in a group setting was compared with the already established robot-assisted therapy method. * Significantly more patients in the group treated with CUREO® showed clinically relevant improvements in arm functionality * The extent of improvement in the group treated with CUREO® was significantly greater than in the comparison group. The study entitled "Neurorehabilitation of the upper extremity - immersive virtual reality vs. electromechanically assisted training. A comparative study" was published in December 2023 in the established journal Frontiers in Neurology. Find out more about the current state of research on virtual reality on our website www.cureosity.com and arrange your personal consultation today via the link in our bio. #CUREO #EN
-
Treat up to 6 patients in parallel: with CUREO® GROUP! Group therapy is intuitive for therapists: simply select the training plan and provide assistance when required. This relieves your staff and at the same time increases the therapy frequency for your patients - while maintaining the same therapy quality. Arrange your personal consultation today via the link in our bio and find out more on our website www.cureosity.com #CUREO #EN
-
Thanks to everyone who visited us at our stand at the occupational therapy congress in Rostock, organized by Deutscher Verband Ergotherapie e.V. last week. It was a really great event with lots of interested visitors and exciting discussions with our colleagues Jannik Schmitz and Artur Jastrzebski. We look forward to coming back next year! Would you also like to get to know CUREO®? Then arrange your personal consultation today via https://lnkd.in/eDardC5c and find out more at www.cureosity.com. #Events #EN
-